BRIAN O'DONNELL

Allopathic & Osteopathic Physicians|Family Medicine PHILADELPHIA, PA NPI 1770106593

General Payments — all program years on this page

$1,437.44

  • Category: General Payments
  • Program years: PY2020–2024
  • Record count: 71
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $834.09 across 41 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $834.0941

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2020 $66.104
2021 $120.482
2022 $29.872
2023 $386.9022
2024 $834.0941

Records — PY2024 (41)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096638865 Novo Nordisk Inc $18.93 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096669789 Novo Nordisk Inc $18.93 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096811236 Novo Nordisk Inc $21.07 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097046115 Novo Nordisk Inc $20.19 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097055853 Novo Nordisk Inc $25.15 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097218989 Novo Nordisk Inc $14.76 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097350190 Novo Nordisk Inc $15.58 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097409852 Novo Nordisk Inc $18.22 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097511870 Novo Nordisk Inc $18.69 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097612169 Novo Nordisk Inc $15.98 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097616880 Novo Nordisk Inc $20.64 08/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097656219 Novo Nordisk Inc $19.73 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097766005 Novo Nordisk Inc $18.65 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097832058 Novo Nordisk Inc $19.88 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101411721 E.R. Squibb & Sons, L.L.C. $16.62 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105141258 ABBVIE INC. $18.69 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105287337 AstraZeneca Pharmaceuticals LP $40.33 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105314878 AstraZeneca Pharmaceuticals LP $15.17 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105498860 AstraZeneca Pharmaceuticals LP $24.57 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105638114 AstraZeneca Pharmaceuticals LP $26.55 11/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105831951 AstraZeneca Pharmaceuticals LP $21.67 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105856146 AstraZeneca Pharmaceuticals LP $14.23 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105875915 AstraZeneca Pharmaceuticals LP $13.66 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105882339 AstraZeneca Pharmaceuticals LP $13.21 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111664542 Amgen Inc. $17.47 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111664544 Amgen Inc. $18.15 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111664546 Amgen Inc. $16.78 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114814395 Exact Sciences Corporation $16.19 02/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114814400 Exact Sciences Corporation $16.63 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114814406 Exact Sciences Corporation $21.40 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114814412 Exact Sciences Corporation $25.49 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114814418 Exact Sciences Corporation $19.71 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117342120 Amgen Inc. $19.09 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117342122 Amgen Inc. $20.57 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117342124 Amgen Inc. $18.44 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136079175 Lilly USA, LLC $21.45 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148897993 Sumitomo Pharma America, Inc. $17.77 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148897995 Sumitomo Pharma America, Inc. $21.83 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148897997 Sumitomo Pharma America, Inc. $16.14 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150123785 SHIELD THERAPEUTICS INC $18.80 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150143266 SHIELD THERAPEUTICS INC $57.08 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.